Financial results - TELKAPHARM SRL

Financial Summary - Telkapharm Srl
Unique identification code: 29800516
Registration number: J2012000050374
Nace: 8621
Sales - Ron
1.974.785
Net Profit - Ron
138.392
Employees
38
Open Account
Company Telkapharm Srl with Fiscal Code 29800516 recorded a turnover of 2024 of 1.974.785, with a net profit of 138.392 and having an average number of employees of 38. The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Telkapharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 272.598 631.942 740.521 773.963 1.036.770 1.149.962 1.356.440 1.327.575 1.680.744 1.974.785
Total Income - EUR 274.447 633.306 741.061 774.352 1.037.490 1.155.931 1.356.464 1.329.355 1.680.748 1.974.793
Total Expenses - EUR 260.764 595.572 709.734 747.538 1.003.606 1.120.977 1.320.914 1.290.541 1.642.084 1.836.400
Gross Profit/Loss - EUR 13.683 37.734 31.327 26.814 33.884 34.955 35.550 38.815 38.664 138.392
Net Profit/Loss - EUR 11.547 30.238 21.933 23.531 27.750 28.713 29.558 32.166 33.282 138.392
Employees 10 19 26 22 29 31 36 34 39 38
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 18.2%, from 1.680.744 euro in the year 2023, to 1.974.785 euro in 2024. The Net Profit increased by 105.296 euro, from 33.282 euro in 2023, to 138.392 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Telkapharm Srl

Rating financiar

Financial Rating -
TELKAPHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Telkapharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Telkapharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Telkapharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Telkapharm Srl - CUI 29800516

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 59.023 96.544 155.512 213.933 175.210 169.704 141.985 308.772 425.462 816.746
Current Assets 222.450 285.803 538.657 650.138 194.527 252.102 328.703 341.921 402.028 495.754
Inventories 75.101 76.077 170.449 171.138 78.260 146.454 121.392 129.953 17.948 14.788
Receivables 146.273 193.242 351.100 465.200 109.214 94.265 163.264 172.133 343.938 440.905
Cash 1.076 16.484 17.108 13.799 7.053 11.384 44.047 39.835 40.143 40.062
Shareholders Funds 174.441 202.900 221.400 240.868 260.507 284.282 307.536 340.656 372.906 509.214
Social Capital 0 22.268 21.891 21.489 21.073 20.674 20.215 20.278 20.216 20.103
Debts 107.032 179.447 490.045 623.203 256.199 281.707 304.138 451.317 522.810 803.287
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 495.754 euro in 2024 which includes Inventories of 14.788 euro, Receivables of 440.905 euro and cash availability of 40.062 euro.
The company's Equity was valued at 509.214 euro, while total Liabilities amounted to 803.287 euro. Equity increased by 138.392 euro, from 372.906 euro in 2023, to 509.214 in 2024.

Risk Reports Prices

Reviews - Telkapharm Srl

Comments - Telkapharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.